Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.03    -0.07 (-3.33%)
Bid:
2.00
Ask:
2.07
Spread: 0.07 (3.50%)
Market Cap: £2.09m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

New litigation project

14 Jan 2019 07:00

RNS Number : 9405M
Litigation Capital Management Ltd
14 January 2019
 

14 January 2019

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

New litigation project

 

Litigation Capital Management Limited (AIM:LIT) (LCM), a leading international provider of litigation financing solutions, today announces that it has entered into an agreement to provide litigation finance in relation to proceedings which are currently being undertaken in Australasia. These proceedings relate to a commercial dispute regarding the division of significant global assets, which are currently owned by a partnership.

 

The project has a capital commitment to be provided by LCM of A$5.5 million. The terms of the funding agreement are subject to confidentiality between the parties involved and are therefore undisclosed.

 

LCM is managing a portfolio of 17 projects (unconditionally financed), including the project announced today.

 

Patrick Moloney, CEO of LCM, said: 

"This investment is a further example of LCM diversifying its portfolio of litigation finance projects across industry sector and capital commitment size, ensuring that the company's investments and potential returns are uncorrelated.

 

"Following the recent expansion of LCM into the UK and Europe we expect to see further future diversification in our portfolio of projects both by geographic location and jurisdiction."

 

-ENDS-

 

CONTACTS

 

Litigation Capital Management

Patrick Moloney, Chief Executive Officer

Nick Rowles-Davies, Executive Director

 

Canaccord (Nomad and Broker) Tel: 020 7523 8000

Sunil Duggal / Emma Gabriel / Michael Reynolds

 

Hawthorn Advisors lcm@hawthornadvisors.com

Lorna Cobbett / Zinka MacHale Tel: 020 3745 4960

 

NOTES TO EDITORS

 

About LCM

Litigation Capital Management ("LCM") is a leading international provider of litigation financing solutions. This includes single-case and portfolio; across class actions, commercial claims, claims arising out of insolvency and international arbitration. LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management. Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM has been listed on AIM since December 2018, trading under the ticker LIT. www.lcmfinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKNDQOBKDADD
Date   Source Headline
28th Mar 20191:32 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSGlobal cooperation agreement with law firm
20th Mar 20199:56 amRNSSettlement in principle of litigation project
8th Mar 20197:00 amRNSJSOP Award
7th Mar 20195:08 pmRNSAppointment of Jonathan Moulds as Chairman
4th Mar 20197:00 amRNSHalf-year Report
20th Feb 20198:00 amRNSNotice of Results
18th Feb 201912:05 pmRNSHolding(s) in Company
15th Feb 20197:00 amRNSHolding(s) in Company
6th Feb 201910:44 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSNew litigation project
21st Dec 20181:08 pmRNSHolding(s) in Company
21st Dec 20187:30 amRNSHolding(s) in Company
21st Dec 20187:01 amRNSSettlement of litigation project
21st Dec 20187:00 amRNSCompletion of delisting from ASX
19th Dec 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.